Copyright
©The Author(s) 2022.
World J Cardiol. Apr 26, 2022; 14(4): 220-230
Published online Apr 26, 2022. doi: 10.4330/wjc.v14.i4.220
Published online Apr 26, 2022. doi: 10.4330/wjc.v14.i4.220
Figure 4 Comparison of the anti-fibrotic efficacies of finerenone vs eplerenone in aldosterone-treated cardiomyocytes in the presence or absence of G protein-coupled receptor-kinase 5.
mRNA levels of PAI-1 (A) and fibronectin (B), in response to a 2-h-long treatment of 100 nmol/L aldosterone in the presence of either 10 mmol/L eplerenone (Epl) or 10 mmol/L finerenone in control (mock, empty vector CRISPR lentivirus-infected) or in G protein-coupled receptor-kinase (GRK)-5-KO (rat GRK5-targeting CRISPR lentivirus-infected) cells. 18S rRNA levels were used for normalization of the results. aP < 0.05, vs Epl; n = 3 independent measurements per cell clone/treatment performed in triplicate. Epl: Eplerenone; Fin: Finerenone.
- Citation: Pollard CM, Suster MS, Cora N, Carbone AM, Lymperopoulos A. GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone. World J Cardiol 2022; 14(4): 220-230
- URL: https://www.wjgnet.com/1949-8462/full/v14/i4/220.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i4.220